EPZM - Epizyme, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
941.32M
Enterprise Value 3
658.6M
Trailing P/E
N/A
Forward P/E 1
-4.85
PEG Ratio (5 yr expected) 1
-0.13
Price/Sales (ttm)
40.07
Price/Book (mrq)
3.26
Enterprise Value/Revenue 3
28.04
Enterprise Value/EBITDA 6
-4.58

Trading Information

Stock Price History

Beta (3Y Monthly) 2.05
52-Week Change 326.45%
S&P500 52-Week Change 38.78%
52 Week High 316.59
52 Week Low 35.14
50-Day Moving Average 311.15
200-Day Moving Average 312.49

Share Statistics

Avg Vol (3 month) 3633.92k
Avg Vol (10 day) 3411.8k
Shares Outstanding 591.04M
Float 70.52M
% Held by Insiders 14.94%
% Held by Institutions 193.24%
Shares Short (Sep 30, 2019) 48.34M
Short Ratio (Sep 30, 2019) 410.8
Short % of Float (Sep 30, 2019) 412.37%
Short % of Shares Outstanding (Sep 30, 2019) 49.16%
Shares Short (prior month Aug 30, 2019) 48.09M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-615.38%

Management Effectiveness

Return on Assets (ttm)-29.59%
Return on Equity (ttm)-52.04%

Income Statement

Revenue (ttm)23.49M
Revenue Per Share (ttm)0.31
Quarterly Revenue Growth (yoy)-50.80%
Gross Profit (ttm)-84.13M
EBITDA -143.67M
Net Income Avi to Common (ttm)-141.18M
Diluted EPS (ttm)-1.86
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)330.98M
Total Cash Per Share (mrq)3.64
Total Debt (mrq)10.83M
Total Debt/Equity (mrq)3.32
Current Ratio (mrq)10.56
Book Value Per Share (mrq)3.17

Cash Flow Statement

Operating Cash Flow (ttm)-131.82M
Levered Free Cash Flow (ttm)-81.18M